Laboratory recognized for meeting highest international regulatory, safety standards
Princeton, N.J., July 29, 2011 — Covance Inc.(NYSE: CVD), a market leader in nutritional testing, announced today that the International Organization for Standardization (ISO) awarded full 17025 accreditation to its nutritional chemistry and food safety facility in Battle Creek, Mich. Granted by the American Association for Laboratory Accreditation, ISO accreditation confirms compliance with AOAC INTERNATIONAL guidelines for laboratories performing microbiological and chemical analyses of food and pharmaceuticals.
“Recognizing the need for faster and more advanced food safety testing, Covance built a state-of-the-art facility in Battle Creek,” said Marlo Vasquez, Vice President and General Manager, Covance Nutritional Chemistry and Food Safety. “This accreditation demonstrates not only our ability to consistently meet the highest testing standards, ensuring the safety of our clients’ products, but also our capacity to serve our clients’ growing needs in microbiology. The extraordinary commitment and collaboration of our entire food testing team enabled us to achieve this important milestone within our first year of operation.”
The ISO accreditation reaffirms strong client confidence in Covance and presents new opportunities within the microbiology and nutritional chemistry marketplace. Since opening in October 2010, with Kellogg’s as the anchor client, Covance has expanded its client base in Battle Creek to include companies manufacturing a wide range of food products and ingredients. Through its affiliation with the Global Food Protection Institute, the company has increased awareness of advancements in food protection and helped to establish the area as a food safety hub.
ISO 17025 in Battle Creek follows successful accreditation of the company’s nutritional chemistry and food safety laboratories in Madison, Wis. (2009) and Singapore (2008). With more than 75 years of experience in nutritional testing, Covance plays a leading role in the design of testing programs required to meet nutrition facts labeling regulations and scientific standards.
About Covance Inc.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services and food testing companies with annual revenues greater than $1.9 billion, global operations in more than 30 countries, and more than 10,500 employees worldwide. Information on Covance’s products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.
Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss or delay of large studies, risks associated with acquisitions and investments, the Company's ability to increase order volume, the pace of translation of orders into revenue in late-stage development services, testing mix and geographic mix of kit receipts in central laboratories, fluctuations in currency exchange rates, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.
# # #